Sebivo and blood creatine phosphokinase mb Patient Reports February 12, 2012



Sebivo Side Effects Report #5869917-5
Sebivo side effect was reported by a Physician from CHINA on Aug 27, 2008. Male patient, 20 years of age, was diagnosed with hepatitis b What is  hepatitis b and was treated with Sebivo. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alpha hydroxybutyrate dehydrogenase increased, aspartate aminotransferase increased, asthenia, blood creatine phosphokinase increased, blood creatine phosphokinase mb, blood immunoglobulin e increased, blood lactate dehydrogenase increased, blood uric acid increased. Sebivo dosage: 600 MG, QD. During the same period patient was treated with PEGASYS. Patient was hospitalized. Patient recovered.

Sebivo Side Effects Report #5840687-X
Sebivo side effect was reported by a Physician from CHINA on Aug 04, 2008. Female patient was diagnosed with hepatitis b What is  hepatitis b and was treated with Sebivo. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, blood bilirubin unconjugated increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb, blood lactate dehydrogenase increased. Sebivo dosage: 600 MG QD. Patient was hospitalized. Patient died on 08/04/2008.

Sebivo Side Effects Report #5931963-0
Sebivo side effect was reported by a Physician from CHINA on Oct 21, 2008. Male patient, weighting 130.1 lb, was diagnosed with hepatitis b What is  hepatitis b and was treated with Sebivo. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, blood bilirubin unconjugated increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb, blood gases abnormal. Sebivo dosage: 600 MG QD. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient died on 08/04/2008.

Sebivo Side Effects Report #5782421-8
Sebivo side effect was reported by a Physician from on June 12, 2008. Male patient, 20 years of age, was treated with Sebivo. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alpha hydroxybutyrate dehydrogenase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb, blood immunoglobulin e increased, blood lactate dehydrogenase increased, blood uric acid increased, c-reactive protein increased. Sebivo dosage: unknown. During the same period patient was treated with PEGASYS. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Sebivo